Published in Vaccine Weekly, November 24th, 1997
The vaccine, which contains no biologically derived components, could represent the first stage in the development of a new generation "minimalist" vaccines with potentially fewer side-effects than their conventional counterparts.
The work, carried out by a team led by Dr. Geert-Jan Boons, is partly funded by the Engineering and Physical Sciences Research Council.
While synthetic vaccines are unlikely to become available for several years, the research has demonstrated that it should be feasible to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly